CC (%) | CG (%) | GG (%) | Total (%) | P-value | |||
---|---|---|---|---|---|---|---|
Diabetic nephropathy | Mortality | Yes | 42 (30) | 62 (44) | 36 (26) | 140 (100) | 0.369 |
No | 84 (27) | 158 (51) | 66 (22) | 308 (100) | |||
Cardiovascular (CV) death | Yes | 20 (27) | 35 (48) | 18 (25) | 73 (100) | 0.915 | |
No | 106 (28) | 185 (49) | 84 (23) | 375 (100) | |||
Non-fatal CV event | Yes | 40 (35) | 50 (43) | 25 (22) | 115 (100) | 0.173 | |
No | 86 (26) | 170 (51) | 77 (23) | 333 (100) | |||
End-stage renal failure | Yes | 29 (30) | 46 (47) | 23 (23) | 98 (100) | 0.886 | |
No | 97 (28) | 174 (50) | 79 (22) | 350 (100) | |||
Normoalbuminuria | Mortality | Yes | 14 (40) | 15 (43) | 6 (17) | 35 (100) | 0.394 |
No | 112 (29) | 186 (48) | 86 (22) | 384 (100) | |||
Cardiovascular (CV) death | Yes | 4 (31) | 6 (46) | 3 (23) | 13 (100) | 0.991 | |
No | 122 (30) | 195 (48) | 89 (22) | 406 (100) | |||
Non-fatal CV event | Yes | 15 (37) | 20 (49) | 6 (14) | 41 (100) | 0.415 | |
No | 111 (29) | 181 (48) | 86 (23) | 378 (100) | |||
Microalbuminuria | Yes | 21 (38) | 25 (45) | 9 (16) | 55 (100) | 0.306 | |
No | 105 (29) | 176 (48) | 83 (23) | 364 (100) | |||
Development of nephropathy | Yes | 0 (0) | 1 (100) | 0 (0) | 1 (100) | 0.581 | |
No | 126 (30) | 200 (48) | 92 (22) | 418 (100) |